Fluphenazine Hydrochloride

CHEMBL1448187 Phase 4 معتمد Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

510.4 g/mol

LogP

—

Phase

4

This hydrochloride salt of fluphenazine is an oral antipsychotic used in the treatment of schizophrenia and psychotic disorders by blocking dopamine receptors in the brain. It requires careful dose adjustment to balance therapeutic effects with movement-related side effects.

الوزن الجزيئي

510,4000 g/mol

TPSA

55,30 Å²

المجالات العلاجية

Schizophrenia Generalized Anxiety Disorder Psoriasis

آلية العمل

Blocks dopamine D2 receptors in the mesolimbic pathway, reducing excessive dopaminergic neurotransmission associated with psychotic symptoms. Many also antagonize serotonin 5-HT2A receptors, which may improve negative symptoms and reduce extrapyramidal side effects.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Blocks dopamine D2 receptors in the mesolimbic pathway, reducing excessive dopaminergic neurotransmission associated with psychotic symptoms. Many also antagonize serotonin 5-HT2A receptors, which may improve negative symptoms and reduce extrapyramidal …

البنية ثنائية الأبعاد

SVG PNG

Cite this structure

Embed this structure

SMILES

Cl.Cl.OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1

InChI

InChI=1S/C22H26F3N3OS.2ClH/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29;;/h1-2,4-7,16,29H,3,8-15H2;2*1H

Molecular Formula

C22H28Cl2F3N3OS

HBD / HBA

3 / 8

الروابط القابلة للدوران

6

الذرات الثقيلة

32

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This hydrochloride salt of fluphenazine is an oral antipsychotic used in the treatment of schizophrenia and psychotic disorders by blocking dopamine receptors in the brain. It requires careful dose adjustment to balance therapeutic effects with movement-related side effects.

Blocks dopamine D2 receptors in the mesolimbic pathway, reducing excessive dopaminergic neurotransmission associated with psychotic symptoms. Many also antagonize serotonin 5-HT2A receptors, which may improve negative symptoms and reduce extrapyramidal side effects.

Yes, Fluphenazine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1448187. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 67356. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Fluphenazine Hydrochloride على PillFYI

البنية

بيانات سريعة

الصيغة الجزيئية: C22H28Cl2F3N3OS
المرادفات: 1

روابط خارجية

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.